Author: Hamish Negi - Page 3

16Jan
Antitrust Laws and Competition Issues in Generic Pharmaceutical Markets
Hamish Negi

Antitrust laws in generic drug markets are meant to lower prices and increase access, but big pharma uses legal tricks like pay-for-delay deals and product hopping to block competition. Here’s how it works - and who pays the price.

15Jan
Statin-Induced Muscle Pain: What You Need to Know About Myalgia and Myositis
Hamish Negi

Statin-induced muscle pain affects up to 30% of users. Learn the difference between myalgia and myositis, why it happens, how it's diagnosed, and what actually works to treat it-without giving up heart protection.

14Jan
NAFLD vs. NASH: Understanding Fatty Liver Progression and Fibrosis Risk
Hamish Negi

NAFLD and NASH are two stages of fatty liver disease. NAFL is simple fat buildup; NASH includes inflammation and liver damage that can lead to fibrosis and cirrhosis. Early detection and lifestyle changes can reverse progression.

13Jan
Meglitinides and Hypoglycemia: Why Skipping Meals Is Dangerous with These Diabetes Drugs
Hamish Negi

Meglitinides like repaglinide and nateglinide help control blood sugar after meals but carry a high risk of hypoglycemia if meals are skipped. Learn how to use them safely with meal timing, reminders, and monitoring.

12Jan
Topical vs. Oral Meds: Systemic Absorption and Safety
Hamish Negi

Topical meds deliver pain relief with far less risk than oral pills. Learn how systemic absorption differs, why safety profiles vary, and which option is right for your pain.

11Jan
Corticosteroids for Autoimmune Disease: Benefits and Long-Term Effects
Hamish Negi

Corticosteroids quickly reduce inflammation in autoimmune diseases like lupus and rheumatoid arthritis, but long-term use carries serious risks including bone loss, cataracts, and adrenal suppression. Learn how to use them safely.

10Jan
Liver Disease and Drug Metabolism: How Reduced Clearance Affects Medication Safety
Hamish Negi

Liver disease reduces the body's ability to clear drugs, leading to dangerous buildup. Learn how enzyme changes, blood flow loss, and dosing guidelines affect medication safety in cirrhosis and other liver conditions.

9Jan
Mandatory vs Permissive Substitution: What State Laws Really Mean for Your Medications
Hamish Negi

Mandatory and permissive substitution laws determine whether pharmacists must or can switch your brand-name prescription to a cheaper generic. These state-by-state rules affect your costs, adherence, and safety - and they’re not the same across the U.S.

8Jan
Generational Differences in Attitudes Toward Generic Medications
Hamish Negi

Generational attitudes toward generic medications vary widely, with older adults more likely to distrust them despite scientific proof of equivalence. Understanding why - and how to bridge the trust gap - is key to better health outcomes.

7Jan
Biologic Drugs: Why They Can't Be Copied Like Regular Pills
Hamish Negi

Biologic drugs are made from living cells, not chemicals - so they can't be copied exactly like generic pills. Learn why biosimilars are the only option, how they're made, and why even tiny changes matter.